Skip to main content



Admission to the Doctoral Program is subject to passing a competition that is usually announced in the spring and published at the related page. The Notice of Admission contains the list of courses, places and grants available as well as the dates, place, type and content of the tests.

Applicants who pass the selection process are placed on a constantly updated merit list that shows the allocation of places.
Competitors who are found to be admitted to the doctoral courses must submit or have their applications received by the Higher Education Service of UniGe according to the pre-established deadlines published in the announcement.

The PhD program is governed by the rules found at the dedicated page.

The course in brief


The Biotechnology Doctorate in Translational Medicine aims to apply an interdisciplinary approach to human health problems in order to transfer new findings from the basic sciences to clinical practice by overcoming the compartmentalization of the biological and medical sciences.
Doctoral students will be expected to familiarize themselves with methods of interdisciplinary approach, learn communication between different scientific fields, and commit themselves to transforming scientific advances in the basic sciences into new methods for the diagnosis, prevention or treatment of human diseases.

Training Objectives.

The purpose of the Ph.D. is to train researchers with specific skills in the direction and organization of biotechnology research with an impact on Human Health.
The Ph.D. student will be expected to develop design, experimental and analytical skills to the point of attaining autonomous research and project management skills. To this end, interventions are planned, aimed both at increasing the cultural background of doctoral students through courses and seminars on innovative and cutting-edge topics in the field of medical biotechnology and its transfer to the clinic, and at providing practical skills through continuous interaction with faculty on issues related to the specific research topics pursued by doctoral students.

Professional outlets

As part of the new Horizon 2020 program, the European Union is giving ample space to regenerative medicine and innovative therapies. Employment prospects are opening up throughout the country. We report some project ideas that emerged during scheduled meetings with practitioners from industry and academia:

  • Development and production of reagents for cell and molecular biology
  • Development of therapeutic protocols using bioactive molecules
  • Production of bioactive molecules by extraction and purification from biological materials, or by recombinant DNA technology
  • Development and production of novel therapeutic tools for cell therapy and gene therapy
  • Development and production of resorbable biomaterials for use in tissue damage repair


Welcome to the doctoral course in Biotechnology in Translational Medicine.  

Paolo Malatesta

International Collaborations

  • Leiden University Medical Center, Netherlands
  • Erasmus University Rotterdam, Netherlands
  • Basel University Hospital, Basel, Switzerland
  • University Of British Columbia, Vancouver, Canada
  • AO Research Center, Davos, Switzerland

Dedicated site

To get more information, visit the site dedicated to this doctorate.